Owner YAMANOUCHI PHARMACEUTICAL CO., LTD.

Inventors UEDA, Yoshitaka; KATO, Miyuki; MASUNAGA, Yohei; YAMAJI, Noboru; ENDOH, Hideki; TANAKA, Hiroaki; ENDO, Yuki

Pub. Number AU-A-2003254865

PCT Number PCT/JP03/10075

PCT Pub. Number WO2004/015103

Priority 2002-233217 09.08.02 JP

Filing date 7 August 2003

Wipo publication date 25 February 2004

C12N 015/09 Mutation or genetic engineering - Recombinant DNA-technology

C12N 005/00 Undifferentiated human, animal or plant cells, e.g. cell lines

G01N 033/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 033/15 Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 033/566 Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

A61K 038/17 Medicinal preparations containing peptides - from animals

A61K 045/00 Medicinal preparations containing active ingredients not provided for in groups

A61P 003/10 Drugs for disorders of the metabolism

A61P 043/00 Drugs for specific purposes, not provided for in groups

C07K 014/47 Peptides having more than 20 amino acids

C12P 021/02 Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12N 001/15 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 001/19 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 001/21 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material